AJCN EB Program 2010 Early Registration
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lees, C. J
Right arrow Articles by Franke, A. A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lees, C. J
Right arrow Articles by Franke, A. A
Agricola
Right arrow Articles by Lees, C. J
Right arrow Articles by Franke, A. A
American Journal of Clinical Nutrition, Vol. 86, No. 1, 245-250, July 2007
© 2007 American Society for Nutrition


ORIGINAL RESEARCH COMMUNICATION

Bone mass and soy isoflavones in socially housed, premenopausal macaques 1,2,3

Cynthia J Lees, Jay R Kaplan, Haiying Chen, Christopher P Jerome, Thomas C Register and Adrian A Franke

1 From the Wake Forest University School of Medicine, Winston-Salem, NC (CJL, JRK, HC, CPJ, and TCR), and the Cancer Research Center of Hawaii, Honolulu, HI (AAF)

Background: Soy consumption is associated with a lower incidence of hip fracture in Asian than in Western women, an effect often attributed to estrogen-like compounds (isoflavones) in soy. It is not known whether premenopausal soy exposure initiated in adulthood can increase bone mass and thereby reduce fracture risk.

Objective: We aimed to determine whether a high-isoflavone soy diet influences bone mass in soy-naïve, premenopausal cynomolgus monkeys (Macaca fascicularis).

Design: Ninety-four skeletally mature females were randomly assigned to consume diets whose protein content came from either high-isoflavone soy or casein and lactalbumin. Animals were socially housed. Bone mass and circulating isoflavone concentrations were measured at baseline and 19 and 31 mo after the start of treatment; bone biomarkers were measured at baseline and 31 mo.

Results: There were no significant differences at any timepoint in whole-body bone mineral content between casein-fed (112.5 ± 2.1, 119.2 ± 1.9, and 120.7 ± 2.1 g) and soy-fed (117.2 ± 2.1, 122.4 ± 2.0, and 125.4 ± 2.3 g; P = 0.12) monkeys. Similar results were seen for spinal bone mineral density (casein-fed: 0.46 ± 0.01, 0.50 ± 0.01, and 0.52 ± 0.01 g/cm2; soy-fed: 0.47 ± 0.01, 0.51 ± 0.01, and 0.52 ± 0.01 g/cm2; P = 0.30) and bone biomarker measurements—bone-specific alkaline phosphatase (soy-fed: 82.3 ± 4.1 and 63.2 ± 3.4 ng/mL; casein-fed: 94.1 ± 4.5 and 61.7 ± 4.3 ng/mL; P = 0.22) and C-terminal crosslink of type 1 collagen (soy-fed: 0.944 ± 0.06 and 0.89 ± 0.08 nmol/L; casein-fed: 0.97 ± 0.07 and 0.78 ± 0.06 nmol/L; P = 0.20).

Conclusion: A soy diet high in isoflavones does not significantly affect bone characteristics in initially soy-naïve premenopausal monkeys.

Key Words: Premenopausal monkeys • Macaca fasicularis • soy protein • isoflavones • bone mass • bone biomarkers







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by The American Society for Nutrition